Motivational and Behavioral Economics Informed Intervention for Cannabis Use
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores new ways to help people who use cannabis by focusing on patient-centered outcomes. It compares two approaches: regular care and a combination of motivational techniques with behavioral economics, which examines decision-making. The goal is to determine which method better supports individuals in changing their cannabis use habits. Individuals who currently use cannabis regularly and have access to a phone or computer might be suitable for this trial. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could shape future cannabis use interventions.
What prior data suggests that this method is safe for promoting patient-centered outcomes?
Research has shown that behavioral treatments, like the one in this trial, are generally safe. Studies have found that these methods can help people reduce cannabis use without causing serious side effects. A review of several trials found that participants handle these treatments well. Most people experience only minor issues, mainly related to the difficulty of changing habits rather than the treatment itself. The goal is to help people make healthier choices, which usually doesn’t lead to harmful effects. Thus, this treatment appears safe for those interested in joining such trials.12345
Why are researchers excited about this trial?
Researchers are excited about the Motivational and Behavioral Economics Informed Intervention for cannabis use because it combines motivational interviewing with principles from behavioral economics, which is different from most current treatments like cognitive-behavioral therapy and contingency management. This approach aims to reduce cannabis use by enhancing personal motivation and leveraging economic principles to influence decision-making. By integrating these elements, the intervention offers a novel way to address the psychological and behavioral aspects of cannabis use, potentially leading to more effective and sustainable outcomes.
What evidence suggests that this trial's treatments could be effective for cannabis use?
This trial will compare two approaches: the Motivational and Behavioral Economics Informed Intervention (MI-BE) and Enhanced Usual Care (EUC). Studies have shown that motivational techniques and strategies from behavioral economics, similar to those in the MI-BE arm, can help people reduce cannabis use. In one study, participants who received this approach were more likely to stop using cannabis, with 74.6% reducing their use compared to 63.9% in a group without the intervention. Another review found that combining motivational enhancement therapy (MET) with cognitive behavioral therapy (CBT) significantly decreased cannabis use frequency. These therapies change how people think about and respond to their cannabis use. This evidence suggests these methods can effectively help those who want to cut down or quit using cannabis.13678
Who Is on the Research Team?
Erin Bonar, PhD
Principal Investigator
University of Michigan
Lara Coughlin, PhD
Principal Investigator
University of Michigan
Are You a Good Fit for This Trial?
This trial is for people who use cannabis and are interested in changing their cannabis-related behaviors. Specific inclusion or exclusion criteria were not provided, but participants should be willing to take part in an intervention about their cannabis use.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a remote behavioral economics-based intervention to address cannabis use
Follow-up
Participants are monitored for changes in cannabis use, depressive symptoms, and anxiety symptoms
What Are the Treatments Tested in This Trial?
Interventions
- Enhanced Usual Care
- Motivational and Behavioral Economics Informed Intervention
Trial Overview
The study compares a new motivational and behavioral economics-based program with enhanced usual care to see which helps people better manage or reduce their cannabis use.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
Citations
Cost-Effectiveness of Motivational Interviewing to Reduce ...
MI resulted in greater likelihood of abstaining from unhealthy alcohol use (70.0% vs. 60.2%, p < .01) and cannabis use (74.6% vs. 63.9%, p < .01) than the ...
A Systematic Review of Randomized Controlled Trials
Across the 15 included RCTs, several intervention modalities demonstrated effectiveness in reducing cannabis use behaviors and cannabis-related harms among ...
Effectiveness of cognitive behavioral therapy for harmful ...
A review based on 23 trials reported that CBT, MET, and particularly the combination of two significantly reduced the frequency of cannabis use and improved ...
A MIXED-METHODS STUDY
The survey will assess marijuana use patterns, motivational factors, and reported psychological, cognitive, and social outcomes.
Behavioral Interventions and Pharmacotherapies for ...
Effectiveness of cannabis use and cannabis use disorder interventions: a European and international data synthesis. Article Open access 23 ...
Cannabis Use Disorder: A Behavioral Economic Perspective
Abstract. Purpose of Review. To explore relations between behavioral economic demand for cannabis and cannabis use disorder (CUD).
Effectiveness and safety of psychosocial interventions for ...
Aim To evaluate the effectiveness, safety and cost-effectiveness of psychosocial interventions for cannabis use disorder (CUD).
Cannabis Prevention Toolkit
Data ... They demonstrated a direct negative relation between. PBSM and cannabis outcomes (i.e., less frequent cannabis use, fewer adverse consequences).
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.